↓ Skip to main content

Dove Medical Press

γ-H2AX expression detected by immunohistochemistry correlates with prognosis in early operable non-small cell lung cancer

Overview of attention for article published in OncoTargets and therapy, October 2012
Altmetric Badge

Mentioned by

facebook
1 Facebook page

Citations

dimensions_citation
44 Dimensions

Readers on

mendeley
43 Mendeley
Title
γ-H2AX expression detected by immunohistochemistry correlates with prognosis in early operable non-small cell lung cancer
Published in
OncoTargets and therapy, October 2012
DOI 10.2147/ott.s36995
Pubmed ID
Authors

Dimitrios Matthaios, Periklis G Foukas, Maria Kefala, Panagiotis Hountis, Grigorios Trypsianis, Ioannis G Panayiotides, Ekaterini Chatzaki, Ekaterini Pantelidaki, Demosthenes Bouros, Petros Karakitsos, Stylianos Kakolyris

Abstract

Phosphorylation of the H2AX histone is an early indicator of DNA double-strand breaks and of the resulting DNA damage response. In the present study, we assessed the expression and prognostic significance of γ-H2AX in a cohort of 96 patients with operable non-small cell lung carcinoma.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 43 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 2%
Unknown 42 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 9 21%
Student > Master 5 12%
Researcher 5 12%
Professor 5 12%
Student > Bachelor 4 9%
Other 4 9%
Unknown 11 26%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 12 28%
Agricultural and Biological Sciences 10 23%
Medicine and Dentistry 6 14%
Immunology and Microbiology 1 2%
Nursing and Health Professions 1 2%
Other 2 5%
Unknown 11 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 October 2012.
All research outputs
#22,759,802
of 25,374,647 outputs
Outputs from OncoTargets and therapy
#2,078
of 3,016 outputs
Outputs of similar age
#171,292
of 190,995 outputs
Outputs of similar age from OncoTargets and therapy
#15
of 18 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,016 research outputs from this source. They receive a mean Attention Score of 2.9. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 190,995 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 18 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.